Toth Financial Advisory’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.75K Buy
+10
New +$5.94K ﹤0.01% 626
2026
Q2
– Sell
-40
Closed -$19.7K – 1005
2026
Q1
$19.7K Buy
40
+39
+3,900% +$21.2K ﹤0.01% 489
2025
Q4
$580 Buy
+1
New +$566 ﹤0.01% 805
2024
Q3
– Sell
-5
Closed -$2.77K – 774
2024
Q2
$2.77K Buy
+5
New +$2.86K ﹤0.01% 578
2023
Q3
– Sell
-10
Closed -$5.22K – 848
2023
Q2
$5.22K Sell
10
-2
-17% -$1.08K ﹤0.01% 549
2023
Q1
$6.92K Buy
+12
New +$6.76K ﹤0.01% 503
2022
Q4
– Sell
-74
Closed -$38K – 804
2022
Q3
$38K Buy
74
+73
+7,300% +$40.9K 0.01% 301
2022
Q2
$1K Buy
+1
New +$550 ﹤0.01% 673
2018
Q1
– Sell
-108
Closed -$21K – 459
2017
Q4
$21K Buy
+108
New +$20.7K 0.01% 273

Other funds holding TMO

Toth Financial Advisory's TMO Position: Q3 2026 in Review

Toth Financial Advisory opened a new position in Thermo Fisher Scientific (TMO) in Q3 2026: 10 shares worth $6.75K. The stake represents ﹤0.01% of the portfolio and ranks #626 among its holdings. This is a return to the name: Toth Financial Advisory previously reported a position in TMO as recently as Q1 2026.

Toth Financial Advisory first reported a position in TMO in Q4 2017 and has held it in 9 quarters since. The position peaked at $38K in Q3 2022. 134 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Toth Financial Advisory held 10 shares of Thermo Fisher Scientific worth $6.75K as of Q3 2026.
  • Thermo Fisher Scientific was a new Toth Financial Advisory position in Q3 2026.
  • Thermo Fisher Scientific made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #626 holding.
  • Toth Financial Advisory first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 9 quarters since.
  • Toth Financial Advisory's Thermo Fisher Scientific position peaked at $38K in Q3 2022.
  • 134 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.